Rocket Lab Stock Falls 10.8% as SpaceX IPO Triggers Sector Rotation

Rocket Lab RKLB shares fell 10.8% to $102.39 on June 12 after a volatile trading day that mixed positive index inclusion news with broader sector rotation. The aerospace company initially surged over 8% in pre-market trading on its Nasdaq-100 Index inclusion announcement, effective June 22. However, SpaceX’s IPO debut at $135 per share and subsequent 19% first-day rally triggered profit-taking across competing space stocks, sending RKLB lower by day’s end.

Nasdaq-100 Inclusion Overshadowed by SpaceX Debut

Rocket Lab announced it will join the Nasdaq-100, an index of the 100 largest non-financial companies on Nasdaq, effective June 22. Inclusion typically drives buying from index-tracking funds. The stock soared over 8% in pre-market trading on this news alone. However, SpaceX’s trading debut under ticker SPCX at $150 per share, up 19% from its $135 IPO price, sparked a broader sector rotation. Investors sold Rocket Lab and other space stocks to lock in profits and shift capital to the newly public SpaceX, which raised a record $75 billion.

Space Sector Faces Competitive Repricing

SpaceX’s filing showed it launched 134 Falcon rockets in 2024, up from 96 in 2023, with Starlink deployments rising to 89 launches from 63 the prior year. This operational cadence advantage prompted a sector-wide reassessment. Virgin Galactic fell 24%, AST SpaceMobile dropped 10%, and Rocket Lab declined 8% in early trading, as investors repriced valuations around SpaceX’s demonstrated launch reliability and reusability. Rocket Lab had gained 38.3% year-to-date before today’s selloff, making it vulnerable to profit-taking.

Extreme Volatility Signals Market Uncertainty

Rocket Lab shares have recorded 86 moves greater than 5% over the past year, reflecting the stock’s extreme sensitivity to sector news. Meyka rates RKLB a C- with a Strong Sell recommendation based on weak profitability metrics. The company posted negative earnings per share of -$0.32 and negative operating cash flow. Technical indicators show the RSI at 43.93, suggesting oversold conditions, while the stock trades at a price-to-sales ratio of 87.98x, well above typical aerospace valuations.

What This Means for Investors

Rocket Lab’s Nasdaq-100 inclusion should attract passive index fund buying starting June 22, providing a potential floor for the stock. However, Meyka’s 12-month forecast of $112.01 sits only 9.4% above the current price, suggesting limited upside. With analyst consensus at Buy (20 analysts) but Meyka’s C- grade reflecting poor fundamentals, the data points to a stock caught between positive index flows and structural profitability challenges. The company reports earnings on August 6.

Final Thoughts

Rocket Lab fell 10.8% to $102.39 on June 12 as SpaceX’s IPO debut triggered sector rotation despite positive Nasdaq-100 inclusion news. Meyka’s C- rating and weak cash flow metrics suggest the stock faces headwinds despite passive index buying ahead.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.